drugset / Trial / NCT05620641

Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy

NCT05620641

Phase 3 Completed 100 enrolled Tanta University
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of this study is to compare the possible efficacy of ondansetron and gabapentin on postoperative nausea and vomiting in patient with morbid obesity who will undergo laparoscopic sleeve gastrectomy.

Timeline

Start
2022-10-01
Primary completion
2025-02-28
Completion
2025-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 600 mg Oral
Subject Ondansetron Other / unclassified 8 mg Intravenous

Indications